| Vitamin D modulation of innate immune responses to respiratory viral infections MT Zdrenghea, H Makrinioti, C Bagacean, A Bush, SL Johnston, ... Reviews in medical virology 27 (1), e1909, 2017 | 320 | 2017 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 264 | 2020 |
| Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro AG Telcian, MT Zdrenghea, MR Edwards, V Laza-Stanca, P Mallia, ... Antiviral research 137, 93-101, 2017 | 179 | 2017 |
| Vitamin D deficiency and the COVID-19 pandemic P Zemb, P Bergman, CA Camargo, E Cavalier, C Cormier, ... Journal of global antimicrobial resistance 22, 133-134, 2020 | 141 | 2020 |
| RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity AG Telcian, V Laza-Stanca, MR Edwards, JA Harker, H Wang, NW Bartlett, ... Journal of Infectious Diseases 203 (1), 85-94, 2011 | 83 | 2011 |
| The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations V Laza-Stanca, SD Message, MR Edwards, HL Parker, MT Zdrenghea, ... PLoS pathogens 7 (7), e1002114, 2011 | 78 | 2011 |
| How to diagnose and treat a cancer of unknown primary site. C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ... Journal of Gastrointestinal & Liver Diseases 26 (1), 2017 | 75 | 2017 |
| The role of macrophage IL‐10/innate IFN interplay during virus‐induced asthma MT Zdrenghea, H Makrinioti, A Muresan, SL Johnston, LA Stanciu Reviews in medical virology 25 (1), 33-49, 2015 | 58 | 2015 |
| RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells MT Zdrenghea, AG Telcian, V Laza-Stanca, CM Bellettato, MR Edwards, ... European Respiratory Journal 39 (3), 712-720, 2012 | 55 | 2012 |
| Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy B Petrushev, S Boca, T Simon, C Berce, I Frinc, D Dima, S Selicean, ... International Journal of Nanomedicine, 641-660, 2016 | 50 | 2016 |
| Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies C Ilcus, C Bagacean, A Tempescul, C Popescu, A Parvu, M Cenariu, ... OncoTargets and therapy, 2349-2363, 2017 | 49 | 2017 |
| TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms … AP Trifa, C Bănescu, M Tevet, A Bojan, D Dima, L Urian, T Török‐Vistai, ... British Journal of Haematology 174 (2), 218-226, 2016 | 40 | 2016 |
| Vitamin D in corona virus disease 2019 (COVID-19) related multisystem inflammatory syndrome in children (MIS-C) G Feketea, V Vlacha, IC Bocsan, E Vassilopoulou, LA Stanciu, ... Frontiers in immunology 12, 648546, 2021 | 39 | 2021 |
| A review of macrophage micrornas’ role in human asthma G Feketea, CI Bocsan, C Popescu, M Gaman, LA Stanciu, MT Zdrenghea Cells 8 (5), 420, 2019 | 35 | 2019 |
| Why do children with acute lymphoblastic leukemia fare better than adults? A Neaga, L Jimbu, O Mesaros, M Bota, D Lazar, S Cainap, C Blag, ... Cancers 13 (15), 3886, 2021 | 34 | 2021 |
| Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ... Critical Reviews in Clinical Laboratory Sciences 55 (7), 501-515, 2018 | 31 | 2018 |
| Advances in the treatment of newly diagnosed primary central nervous system lymphomas L Qian, C Tomuleasa, IA Florian, J Shen, IS Florian, M Zdrenghea, ... Blood research 52 (3), 159, 2017 | 28 | 2017 |
| Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia A Cucuianu, M Stoia, A Farcas, D Dima, M Zdrenghea, M Patiu, D Olinic, ... Rom J Intern Med 44 (4), 397-406, 2006 | 28 | 2006 |
| Is there a place for PD-1-PD-L blockade in acute myeloid leukemia? L Jimbu, O Mesaros, C Popescu, A Neaga, I Berceanu, D Dima, M Gaman, ... Pharmaceuticals 14 (4), 288, 2021 | 24 | 2021 |
| Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises C Bagacean, M Zdrenghea, A Tempescul, V Cristea, Y Renaudineau Immunotherapy 8 (5), 569-581, 2016 | 23 | 2016 |
